STOCK TITAN

Movano Inc SEC Filings

MOVE NASDAQ

Welcome to our dedicated page for Movano SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Movano Inc. (Nasdaq: MOVE) SEC filings page on Stock Titan provides direct access to the company’s official regulatory disclosures, along with AI-powered summaries that help explain their contents in plain language. Movano, doing business as Movano Health, files a range of documents with the U.S. Securities and Exchange Commission that together outline its wearable health technology business, capital structure, and significant corporate events.

Investors can review registration statements such as the Form S-1 that describes a committed equity facility with Chardan Capital Markets LLC, including the potential issuance of up to 110,000,000 shares of common stock under the facility and Movano’s status as an emerging growth company and smaller reporting company. The S-1 and related materials also discuss Nasdaq listing matters, reverse stock split effects on share counts, and stockholders’ equity considerations.

Current reports on Form 8-K document material events, including the Agreement and Plan of Merger with Corvex, Inc., the structure of the all-stock combination, expected ownership percentages of the combined company, and conditions to closing. Other 8-K filings cover the one-for-ten reverse stock split, Nasdaq deficiency notices and extensions, amendments to incentive plans, preferred stock financings, amendments to loan agreements, and stockholder meeting results. These filings provide detail on how Movano is addressing listing requirements, financing needs, and its planned transformation through the Corvex merger.

Definitive proxy statements on Schedule 14A offer insight into stockholder votes on matters such as increasing authorized share capital, approving share issuances under the ChEF Purchase Agreement, amending the omnibus incentive plan, and authorizing reverse stock splits. They also describe virtual special meeting logistics and voting procedures for common and preferred stockholders.

On Stock Titan, each filing is accompanied by AI-generated highlights that point out key terms, risk factors, and structural details, helping users navigate lengthy documents like S-1 registration statements and complex 8-K merger disclosures. The platform also makes it easier to locate quarterly and annual reports when filed (Forms 10-Q and 10-K), as well as any insider transaction reports on Form 4, so users can monitor executive and director share dealings once available.

By using this page, investors can quickly find Movano’s official SEC filings related to its wearable medical devices, financing arrangements, Nasdaq compliance efforts, and the proposed renaming and repositioning of the company as Corvex, Inc. after the merger closes, while relying on AI tools to surface the most important information from each document.

Rhea-AI Summary

Movano furnished a communication by Corvex announcing verified production deployment of confidential computing on NVIDIA HGX B200 systems. The Corvex release describes encrypted GPU-to-GPU communication across NVIDIA NVSwitch and NVLink, integration with Intel Trust Domain Extensions and Intel® Trust Authority remote attestation, and near‑native performance for runtime protection of sensitive models and data.

The filing also reiterates the previously announced definitive merger agreement between Movano and Corvex for an all‑stock combination and references the pending Form S-4 and proxy materials.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.1%
Tags
merger
-
Rhea-AI Summary

Movano Inc. registers 545,456 shares of common stock for resale, representing shares issuable upon conversion of its Series A Preferred Stock at a conversion price of $5.50 per share.

The resale registration states the Company will not receive any proceeds from sales by the Selling Stockholders. The prospectus also discloses a one-for-ten reverse stock split effective October 10, 2025, 1,141,930 shares of common stock issued and outstanding as of February 4, 2026, and that Nasdaq granted an extension to March 30, 2026 to regain the $2.5 million stockholders’ equity listing requirement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Movano Inc. filed an amended resale registration statement covering up to 545,456 shares of common stock issuable on conversion of its Series A Preferred Stock. These shares were sold for $3.0 million of bridge financing and will convert at $5.50 per share, with Movano receiving no proceeds from any resale.

The Series A will automatically convert upon closing Movano’s planned merger with Corvex, an AI cloud computing company, subject to customary conditions and stockholder approval. Movano has also entered into a Chardan equity facility that permits issuances up to $1.0 billion and has registered 110,000,000 shares for resale under that arrangement. As of February 4, 2026, Movano had 1,141,930 shares outstanding; issuing all 545,456 registered shares would increase this to 1,687,386, meaning substantial potential dilution.

The company previously effected a 1‑for‑10 reverse stock split and has disclosed that Corvex holders are expected to own about 94.9% of the combined company after the merger, leaving current Movano holders with approximately 5.1%. Movano is not in compliance with Nasdaq’s $2.5 million stockholders’ equity requirement, having reported stockholders’ equity of approximately $(1.701) million as of September 30, 2025, but has been granted an extension until March 30, 2026 to regain compliance. The prospectus highlights significant risks around dilution, merger execution, supply constraints for AI infrastructure, and the possibility that Movano’s common stock could be delisted if compliance is not restored.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
Rhea-AI Summary

Movano Inc. is registering up to 110,000,000 shares of common stock for resale by Chardan Capital Markets under a committed equity facility. These “Purchase Shares” may be issued over three years under a ChEF Purchase Agreement with a total potential gross purchase price of up to $1,000,000,000.

Movano will not receive proceeds from Chardan’s resale of shares, but will receive cash when it sells newly issued shares to Chardan at a discount to market, subject to an exchange cap, a 4.99% beneficial ownership limit, and Corvex’s prior written consent before the Corvex merger closes. As of February 4, 2026, Movano had 1,141,930 shares outstanding, so full use of the facility could be highly dilutive.

The filing is tied to Movano’s planned merger with AI infrastructure company Corvex, after which the combined company will be renamed Corvex, Inc., with former Corvex holders expected to own about 94.9% of the combined company. Movano recently effected a one‑for‑ten reverse stock split and has an extension from Nasdaq until March 30, 2026 to regain the $2.5M stockholders’ equity listing requirement, with no assurance of success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Movano Inc. has filed an amended registration statement for an all‑stock merger with Corvex, Inc., creating an AI cloud computing company focused on GPU‑accelerated infrastructure. A Movano subsidiary will merge into Corvex, which will become a wholly owned subsidiary, and Movano will be renamed Corvex, Inc.

Based on the current exchange formula, former Corvex securityholders are expected to own about 94.9% of the combined company on a fully diluted basis, while existing Movano holders retain roughly 5.1%. Each Corvex share is expected to convert into approximately 1.8969 Movano shares plus potential stock earnouts tied to future $15 and $25 share‑price targets.

Movano plans to sell its legacy healthcare assets and may distribute any net proceeds to pre‑merger stockholders after debt and reserve payments. The merger requires approval of Movano stockholders, including a Nasdaq‑mandated stock issuance and change‑of‑control vote, as well as adoption of new 2026 equity incentive and employee stock purchase plans. Support agreements already cover about 23.2% of Movano’s outstanding common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Movano Inc. Chief Executive Officer and Director John Mastrototaro reported exercising stock options and related share sales. On January 26, 2026, he exercised 72,834 stock options at an exercise price of $1.25 per share, receiving the same number of common shares.

On January 27, 2026, he sold several blocks of Movano common stock, including 4,512 shares at a weighted average of $19.12, 5,444 shares at $20.18, 14,960 shares at $20.75, 5,746 shares at $21.78, and 2,407 shares at $23.37. A footnote states these sales were made to pay withholding taxes and exercise prices tied to stock option awards granted in lieu of 2025 cash salary. After the transactions, he directly owned 56,114 Movano common shares.

The option exercised was granted contingent on shareholder approval of an amendment to Movano’s Omnibus Incentive Plan increasing authorized shares; it became exercisable upon shareholder approval of the Plan Amendment on December 16, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Movano Inc. CFO Jeremy Cogan reported an option exercise and related share sales. On January 26, 2026, he exercised 64,834 stock options at an exercise price of $1.25 per share, receiving the same number of common shares.

On January 27, 2026, he sold an aggregate of 28,736 common shares in multiple open-market transactions at weighted average prices between $19.11 and $23.37. A footnote states these sales were made to pay withholding taxes and exercise prices tied to option awards granted in lieu of 2025 cash salary. After these transactions, he directly owned 60,504 Movano common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Movano Inc. insider plans a sale of 32614 Class A common shares under Rule 144. The shares are to be sold through J.P. Morgan Securities LLC on the NYSE around 01/27/2026, with an aggregate market value listed as 679426 and 869276 shares outstanding.

The securities to be sold were acquired on 11/03/2025 via a cashless option exercise from Movano Inc., with cash payment dated 01/28/2026. Over the past three months, John Mastrototaro sold 2514 Class A common shares on 01/05/2026 for gross proceeds of 20637.39.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Movano Inc. has a Rule 144 notice covering a planned sale of 28736 shares of its Class A Common Stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of 597193. The filing notes that 869276 shares of this class were outstanding.

The securities to be sold were acquired on 11/03/2025 via a cashless option exercise and sale from Movano Inc., with 84834 securities acquired and cash payment dated 01/28/2026. Over the prior three months, Jeremy Cogan sold 10097 Class A Common Stock shares on 01/07/2026 for gross proceeds of 79119.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Movano Inc. and Corvex filed this communication to highlight a new long-term customer deployment for Corvex ahead of their proposed all-stock merger. Corvex, an AI cloud computing company, has signed a long-term lease agreement to provide a dedicated cluster of NVIDIA H200 GPUs to an AI-driven provider of high-performance battery technologies. The GPUs will support the customer’s core AI research and production workloads.

Corvex is delivering a secure, managed on-premise GPU solution with hardware-enforced encryption, remote attestation, and telemetry designed to meet strict data-sovereignty, compliance, and intellectual property protection requirements. Its platform also includes a fully managed, hyperscaler-class Kubernetes service aimed at maximizing GPU utilization, limiting idle capacity, and simplifying operations so the customer’s engineering team can focus on building AI models. The filing also reiterates the previously announced definitive merger agreement between Movano and Corvex and directs investors to the Form S-4 and proxy statement for detailed information on the proposed transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
140.17%
Tags
merger

FAQ

What is the current stock price of Movano (MOVE)?

The current stock price of Movano (MOVE) is $14.01 as of March 11, 2026.

What is the market cap of Movano (MOVE)?

The market cap of Movano (MOVE) is approximately 16.5M.

MOVE Rankings

MOVE Stock Data

16.52M
689.53k
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLEASANTON

MOVE RSS Feed